Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy

Detalhes bibliográficos
Autor(a) principal: Silva Junior,João Manoel da
Data de Publicação: 2012
Outros Autores: Rezende,Ederlon, Amendola,Cristina Prada, Tomita,Rafael, Torres,Daniele, Ferrari,Maria Tereza, Toledo,Diogo Oliveira, Oliveira,Amanda Maria Ribas Rosa, Marques,Juliana Andreia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802012000200002
Resumo: CONTEXT AND OBJECTIVE: Anemia and blood transfusions are common in intensive care. This study aimed to evaluate epidemiology and outcomes among critically ill patients under a restrictive transfusion strategy. DESIGN AND SETTING: Prospective observational cohort study in an intensive care unit (ICU) at a tertiary hospital. METHODS: All adults admitted to the ICU over a one-year period who remained there for more than 72 hours were included, except those with acute coronary syndrome, ischemic stroke, acute hemorrhage, prior transfusion, pregnant women and Jehovah's Witnesses. The restrictive strategy consisted of transfusion indicated when hemoglobin levels were less than or equal to 7.0 g/dl. RESULTS: The study enrolled 167 patients; the acute physiology and chronic health evaluation II (APACHE II) score was 28.9 ± 6.5. The baseline hemoglobin level was 10.6 ± 2.2 g/dl and on day 28, it was 8.2 ± 1.3 g/dl (P < 0.001). Transfusions were administered to 35% of the patients. In the transfusion group, 61.1% did not survive, versus 48.6% in the non-transfusion group (P = 0.03). Transfusion was an independent risk factor for mortality (P = 0.011; odds ratio, OR = 2.67; 95% confidence interval, CI = 1.25 to 5.69). ICU stay and hospital stay were longer in the transfusion group: 20.0 (3.0-83.0) versus 8.0 (3.0-63.0) days (P < 0,001); and 24.0 (3.0-140.0) versus 14.0 (3.0-80.0) days (P = 0.002), respectively. CONCLUSIONS: In critically ill patients, there was a reduction in hemoglobin with increasing length of ICU stay. Moreover, transfusion was associated with worse prognoses.
id APM-1_992d635221914dcc0e1d99906d298422
oai_identifier_str oai:scielo:S1516-31802012000200002
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategyAnemiaBlood transfusionIntensive careHospital mortalityMorbidityCONTEXT AND OBJECTIVE: Anemia and blood transfusions are common in intensive care. This study aimed to evaluate epidemiology and outcomes among critically ill patients under a restrictive transfusion strategy. DESIGN AND SETTING: Prospective observational cohort study in an intensive care unit (ICU) at a tertiary hospital. METHODS: All adults admitted to the ICU over a one-year period who remained there for more than 72 hours were included, except those with acute coronary syndrome, ischemic stroke, acute hemorrhage, prior transfusion, pregnant women and Jehovah's Witnesses. The restrictive strategy consisted of transfusion indicated when hemoglobin levels were less than or equal to 7.0 g/dl. RESULTS: The study enrolled 167 patients; the acute physiology and chronic health evaluation II (APACHE II) score was 28.9 ± 6.5. The baseline hemoglobin level was 10.6 ± 2.2 g/dl and on day 28, it was 8.2 ± 1.3 g/dl (P < 0.001). Transfusions were administered to 35% of the patients. In the transfusion group, 61.1% did not survive, versus 48.6% in the non-transfusion group (P = 0.03). Transfusion was an independent risk factor for mortality (P = 0.011; odds ratio, OR = 2.67; 95% confidence interval, CI = 1.25 to 5.69). ICU stay and hospital stay were longer in the transfusion group: 20.0 (3.0-83.0) versus 8.0 (3.0-63.0) days (P < 0,001); and 24.0 (3.0-140.0) versus 14.0 (3.0-80.0) days (P = 0.002), respectively. CONCLUSIONS: In critically ill patients, there was a reduction in hemoglobin with increasing length of ICU stay. Moreover, transfusion was associated with worse prognoses.Associação Paulista de Medicina - APM2012-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802012000200002Sao Paulo Medical Journal v.130 n.2 2012reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/S1516-31802012000200002info:eu-repo/semantics/openAccessSilva Junior,João Manoel daRezende,EderlonAmendola,Cristina PradaTomita,RafaelTorres,DanieleFerrari,Maria TerezaToledo,Diogo OliveiraOliveira,Amanda Maria Ribas RosaMarques,Juliana Andreiaeng2012-04-03T00:00:00Zoai:scielo:S1516-31802012000200002Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2012-04-03T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
title Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
spellingShingle Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
Silva Junior,João Manoel da
Anemia
Blood transfusion
Intensive care
Hospital mortality
Morbidity
title_short Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
title_full Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
title_fullStr Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
title_full_unstemmed Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
title_sort Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
author Silva Junior,João Manoel da
author_facet Silva Junior,João Manoel da
Rezende,Ederlon
Amendola,Cristina Prada
Tomita,Rafael
Torres,Daniele
Ferrari,Maria Tereza
Toledo,Diogo Oliveira
Oliveira,Amanda Maria Ribas Rosa
Marques,Juliana Andreia
author_role author
author2 Rezende,Ederlon
Amendola,Cristina Prada
Tomita,Rafael
Torres,Daniele
Ferrari,Maria Tereza
Toledo,Diogo Oliveira
Oliveira,Amanda Maria Ribas Rosa
Marques,Juliana Andreia
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva Junior,João Manoel da
Rezende,Ederlon
Amendola,Cristina Prada
Tomita,Rafael
Torres,Daniele
Ferrari,Maria Tereza
Toledo,Diogo Oliveira
Oliveira,Amanda Maria Ribas Rosa
Marques,Juliana Andreia
dc.subject.por.fl_str_mv Anemia
Blood transfusion
Intensive care
Hospital mortality
Morbidity
topic Anemia
Blood transfusion
Intensive care
Hospital mortality
Morbidity
description CONTEXT AND OBJECTIVE: Anemia and blood transfusions are common in intensive care. This study aimed to evaluate epidemiology and outcomes among critically ill patients under a restrictive transfusion strategy. DESIGN AND SETTING: Prospective observational cohort study in an intensive care unit (ICU) at a tertiary hospital. METHODS: All adults admitted to the ICU over a one-year period who remained there for more than 72 hours were included, except those with acute coronary syndrome, ischemic stroke, acute hemorrhage, prior transfusion, pregnant women and Jehovah's Witnesses. The restrictive strategy consisted of transfusion indicated when hemoglobin levels were less than or equal to 7.0 g/dl. RESULTS: The study enrolled 167 patients; the acute physiology and chronic health evaluation II (APACHE II) score was 28.9 ± 6.5. The baseline hemoglobin level was 10.6 ± 2.2 g/dl and on day 28, it was 8.2 ± 1.3 g/dl (P < 0.001). Transfusions were administered to 35% of the patients. In the transfusion group, 61.1% did not survive, versus 48.6% in the non-transfusion group (P = 0.03). Transfusion was an independent risk factor for mortality (P = 0.011; odds ratio, OR = 2.67; 95% confidence interval, CI = 1.25 to 5.69). ICU stay and hospital stay were longer in the transfusion group: 20.0 (3.0-83.0) versus 8.0 (3.0-63.0) days (P < 0,001); and 24.0 (3.0-140.0) versus 14.0 (3.0-80.0) days (P = 0.002), respectively. CONCLUSIONS: In critically ill patients, there was a reduction in hemoglobin with increasing length of ICU stay. Moreover, transfusion was associated with worse prognoses.
publishDate 2012
dc.date.none.fl_str_mv 2012-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802012000200002
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802012000200002
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1516-31802012000200002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal v.130 n.2 2012
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209263358574592